Consistent with the broad anti-inflammatory effects of C15:0 shown in our current study, daily oral C15:0 supplementation over 12 weeks lowers the proinflammatory cytokines MCP-1, IL-6, and TNFα, as well as IgG, in animal models of metabolic and liver disease [2]. This evidence concerns the gene CCL2 and liver disorder.